FRANKLIN COVEY CO. Proceeds from Lines of Credit
FRANKLIN COVEY CO. (FC) reported Proceeds from Lines of Credit of $11.68 million for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-07-07
- FRANKLIN COVEY CO. proceeds from lines of credit for the quarter ending 2026-05-31 was $0.00.
- FRANKLIN COVEY CO. proceeds from lines of credit for the quarter ending 2025-05-31 was $0.00.
- FRANKLIN COVEY CO. proceeds from lines of credit for the quarter ending 2020-08-31 was $0.00, a 100.00% decline year-over-year.
- FRANKLIN COVEY CO. proceeds from lines of credit for the quarter ending 2019-08-31 was $15.83M, a 28.96% decline year-over-year.
- FRANKLIN COVEY CO. proceeds from lines of credit for fiscal 2020 was $14.87M, a 81.93% decline from fiscal 2019.
- FRANKLIN COVEY CO. proceeds from lines of credit for fiscal 2019 was $82.28M, a 11.90% decline from fiscal 2018.
- FRANKLIN COVEY CO. proceeds from lines of credit for fiscal 2018 was $93.39M, a 172.12% increase from fiscal 2017.
- FRANKLIN COVEY CO. proceeds from lines of credit for fiscal 2017 was $34.32M, a 26.12% decline from fiscal 2016.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-07 | $11.68M 10-Q · filed 2026-07-07 | ||
| 2026-02-28 | $11.68M 10-Q · filed 2026-04-08 | |||
| 2025-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-07 | $0.00 10-Q · filed 2026-07-07 | ||
| 2025-02-28 | $0.00 10-Q · filed 2026-04-08 | |||
| 2020-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-14 | $14.87M 10-K · filed 2022-11-14 | ||
| 2020-05-31 | $14.87M 10-Q · filed 2021-07-08 | |||
| 2019-08-31 | $15.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-12 | $36.25M derived: sum of 2 quarters · filed 2021-11-12 | $59.60M derived: sum of 3 quarters · filed 2021-11-12 | $82.28M 10-K · filed 2021-11-12 |
| 2019-05-31 | $20.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-10 | $43.77M derived: sum of 2 quarters · filed 2020-07-10 | $66.45M 10-Q · filed 2020-07-10 | $88.73M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-02-28 | $23.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-09 | $46.03M 10-Q · filed 2020-04-09 | $68.32M derived: sum of 3 quarters · filed 2020-11-16 | $92.38M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-11-30 | $22.68M 10-Q · filed 2020-01-09 | $44.97M derived: sum of 2 quarters · filed 2020-11-16 | $69.03M derived: sum of 3 quarters · filed 2020-11-16 | $91.44M derived: sum of 4 quarters · filed 2020-11-16 |
| 2018-08-31 | $22.28M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-16 | $46.34M derived: sum of 2 quarters · filed 2020-11-16 | $68.76M derived: sum of 3 quarters · filed 2020-11-16 | $93.39M 10-K · filed 2020-11-16 |
| 2018-05-31 | $24.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-09 | $46.47M derived: sum of 2 quarters · filed 2019-07-09 | $71.11M 10-Q · filed 2019-07-09 | $97.62M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-02-28 | $22.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-09 | $47.05M 10-Q · filed 2019-04-09 | $73.56M derived: sum of 3 quarters · filed 2019-11-14 | |
| 2017-11-30 | $24.63M 10-Q · filed 2019-01-09 | $51.14M derived: sum of 2 quarters · filed 2019-11-14 | ||
| 2017-08-31 | $26.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | $34.32M 10-K · filed 2019-11-14 | ||
| 2017-05-31 | $7.81M 10-Q · filed 2018-07-10 | |||
| 2016-08-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $26.08M derived: sum of 2 quarters · filed 2018-11-14 | $46.45M 10-K · filed 2018-11-14 | |
| 2016-05-28 | $18.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-07-10 | $39.31M 10-Q · filed 2017-07-10 | ||
| 2016-02-27 | $20.37M 10-Q · filed 2016-04-07 | |||
| 2014-08-31 | $8.63M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | $27.96M derived: sum of 2 quarters · filed 2016-11-14 | $35.33M 10-K · filed 2016-11-14 | |
| 2014-05-31 | $19.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-09 | $26.71M 10-Q · filed 2015-07-09 | ||
| 2014-03-01 | $7.38M 10-Q · filed 2015-04-09 | |||
| 2012-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $2.58M derived: sum of 3 quarters · filed 2014-11-14 | $8.52M 10-K · filed 2014-11-14 |
| 2012-05-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-07-11 | $2.58M derived: sum of 2 quarters · filed 2013-07-11 | $8.52M 10-Q · filed 2013-07-11 | $25.35M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-02-25 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-04-11 | $8.52M 10-Q · filed 2013-04-11 | $25.35M derived: sum of 3 quarters · filed 2013-11-14 | $46.31M derived: sum of 4 quarters · filed 2013-11-14 |
| 2011-11-26 | $5.94M 10-Q · filed 2013-01-10 | $22.77M derived: sum of 2 quarters · filed 2013-11-14 | $43.73M derived: sum of 3 quarters · filed 2013-11-14 | $57.14M derived: sum of 4 quarters · filed 2013-11-14 |
| 2011-08-31 | $16.83M derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-14 | $37.79M derived: sum of 2 quarters · filed 2013-11-14 | $51.20M derived: sum of 3 quarters · filed 2013-11-14 | $67.46M 10-K · filed 2013-11-14 |
| 2011-05-28 | $20.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-03 | $34.37M derived: sum of 2 quarters · filed 2012-07-03 | $50.63M 10-Q · filed 2012-07-03 | |
| 2011-02-26 | $13.41M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-04-04 | $29.68M 10-Q · filed 2012-04-04 | ||
| 2010-11-27 | $16.27M 10-Q/A · filed 2012-01-26 | |||
| 2010-08-31 | $54.70M 10-K · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |